Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanjing Medical UniversityActive in the last 2 years

Dong Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-6202-3864; OpenAlex author ID A5101370097. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. The feasibility and potential benefits of administering adjuvant chemotherapy in resected pancreatic cancer patients unable to promptly remove intraperitoneal … Co-author DOI 10.1186/s12885-025-14262-1↗
  2. Efficacy of second-line treatment for gemcitabine-refractory unresectable pancreatic cancer in a real-world setting. Co-author DOI 10.1186/s12885-025-14601-2↗
  3. MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin. Co-author DOI 10.3892/mmr.2013.1504↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yang Feng Wu · 2 shared papers, 2025 · strength 0.50
  2. Jishu Wei · 2 shared papers, 2025 · strength 0.50
  3. Qianqian Wang · 2 shared papers, 2025 · strength 0.50
  4. Min Tu · 2 shared papers, 2025 · strength 0.50
  5. Kai Zhang · 1 shared paper, 2025 · strength 0.26
  6. Yi Miao · 1 shared paper, 2025 · strength 0.26
  7. Kuirong Jiang · 1 shared paper, 2025 · strength 0.26
  8. Wentao Gao · 1 shared paper, 2025 · strength 0.25
  9. Junli Wu · 1 shared paper, 2025 · strength 0.25
  10. Kuirong Jiang · 1 shared paper, 2025 · strength 0.25
  11. Qingguang Wang · 1 shared paper, 2013 · strength 0.05
  12. Yong An · 1 shared paper, 2013 · strength 0.05
  13. Li Xu · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.